Cite
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.
MLA
UCL - SSS/IREC/MORF - Pôle de Morphologie, et al. “Phylogenetic Reconstruction of Breast Cancer Reveals Two Routes of Metastatic Dissemination Associated with Distinct Clinical Outcome.” EBioMedicine, Vol. 56, p. 102793 [1-8] (2020), 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288276952&authtype=sso&custid=ns315887.
APA
UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (SLuc) Service d’anatomie pathologique, Venet, D., Fimereli, D., Rothé, F., Boeckx, B., Maetens, M., Majjaj, S., Rouas, G., Capra, M., Bonizzi, G., Contaldo, F., Galant, C., Piccart, M., Pruneri, G., Larsimont, D., Lambrechts, D., Desmedt, C., & Sotiriou, C. (2020). Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome. EBioMedicine, Vol. 56, p. 102793 [1-8] (2020).
Chicago
UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (SLuc) Service d’anatomie pathologique, David Venet, Danai Fimereli, Françoise Rothé, Bram Boeckx, Marion Maetens, et al. 2020. “Phylogenetic Reconstruction of Breast Cancer Reveals Two Routes of Metastatic Dissemination Associated with Distinct Clinical Outcome.” EBioMedicine, Vol. 56, p. 102793 [1-8] (2020). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288276952&authtype=sso&custid=ns315887.